ArticleAsian journal of andrology2023

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial.

Byung Ha Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.